Exciting Innovations in Cardiac Care: Texas to Host Major Symposium on Arrhythmias

Texas Cardiac Arrhythmia Institute Hosts EPLive 2026

The Texas Cardiac Arrhythmia Institute (TCAI), situated within St. David's Medical Center, is gearing up to host the eighth edition of its internationally acclaimed symposium, EPLive 2026. This significant event will take place on May 28-29, 2026, and aims to unite leading experts in cardiac electrophysiology from around the globe.

EPLive is a biennial symposium that has provided an intensive, two-day educational experience since its inception in 2012. It is primarily targeted at physicians, advanced practice registered nurses, and other allied healthcare professionals focusing on the treatment of complex cardiac arrhythmias — conditions where the heart experiences irregular or abnormal rhythms. This year's conference promises to enhance the learning experience with live cases streamed directly from TCAI's state-of-the-art Electrophysiology Center.

Dr. Andrea Natale, a prominent cardiac electrophysiologist and the executive medical director of TCAI, expressed that "EPLive 2026 represents a unique opportunity for the global electrophysiology community. Real-time learning is facilitated through complex, case-based education, showcasing innovative advancements in the field. The combination of live procedures with expert discussions will offer a practical and impactful experience that professionals can directly apply in practice, ultimately aiming to improve patient outcomes worldwide."

One of the highlights of the symposium this year is a focus on a more streamlined and integrated treatment approach for atrial fibrillation (A Fib) patients who face a higher stroke risk. TCAI will showcase a pioneering procedure that merges two critical interventions — ablation for A Fib and left atrial appendage occlusion (LAAO) — into one session. By simultaneously addressing the heart's abnormal rhythm and the risk factor for stroke, such an approach not only minimizes multiple procedures but also cuts down on time and potential complications, providing safer and more efficient care overall.

The EPLive 2026 agenda includes a series of focused sessions: A Fib ablation, ventricular tachycardia (VT) ablation, LAA closure, and discussions on new devices and technologies in electrophysiology. Engaging presentations will not be limited to merely TCAI; experts from various leading electrophysiology centers worldwide will also contribute. Participating institutions include Belgium's AZ Sint-Jan Brugge and UZ Brussel, Canada's Vancouver General Hospital, Colombia's International Arrhythmia Center, and various prestigious U.S. hospitals such as the Cleveland Clinic, Houston Methodist, and Massachusetts General.

EPLive 2026 will also emphasize several vital educational objectives:

1. Improving processes that ensure patient safety and reduce complications during A Fib ablation and similar procedures.
2. Enhancing knowledge of the latest evidence and guidelines in arrhythmia management, especially with regard to innovative technologies.
3. Optimizing clinical outcomes by leveraging newly demonstrated technologies effectively.
4. Identifying processes ripe for integration of new technologies to promote safer interventions.
5. Emphasizing best practices for managing complex cardiac device implants.

The symposium will see notable presentations from TCAI physicians, including co-directors Dr. Amin Al-Ahmad, Dr. Luigi DiBiase, and Dr. Dhanunjaya "DJ" Lakkireddy. With an extensive faculty lineup, attendees can earn up to 14.5 AMA Physician's Recognition Award (PRA) Category 1 Credit™ hours, adding a valuable educational component to their participation.

Established in 2019, the Texas Cardiac Arrhythmia Institute boasts North America's leading robotic electrophysiology center, spread across a 72,000-square-foot facility with six advanced electrophysiology labs dedicated to treating complex arrhythmias. This center is part of a larger team known for its extensive experience and exceptional care, ranked among the largest electrophysiology practices in the United States.

For those wishing to learn more or participate in this transformative event, further details can be found by visiting EP-Live.com. The upcoming symposium not only marks a major event in the cardiac healthcare calendar but also represents a significant step toward enhancing treatment strategies globally, ensuring better outcomes for patients grappling with complex cardiac conditions.